The current stock price of EXPO is 70.15 USD. In the past month the price decreased by -4.92%. In the past year, price decreased by -21.1%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VRSK | VERISK ANALYTICS INC | 31.85 | 30.80B | ||
| EFX | EQUIFAX INC | 27.83 | 26.20B | ||
| LDOS | LEIDOS HOLDINGS INC | 15.82 | 23.46B | ||
| ULS | UL SOLUTIONS INC - CLASS A | 46.5 | 16.25B | ||
| TRU | TRANSUNION | 19.84 | 16.18B | ||
| J | JACOBS SOLUTIONS INC | 22.08 | 16.07B | ||
| CACI | CACI INTERNATIONAL INC -CL A | 19.59 | 11.87B | ||
| BAH | BOOZ ALLEN HAMILTON HOLDINGS | 13.85 | 10.30B | ||
| AMTM | AMENTUM HOLDINGS INC | 13.67 | 7.42B | ||
| PSN | PARSONS CORP | 19.44 | 6.62B | ||
| PL | PLANET LABS PBC | N/A | 6.28B | ||
| FCN | FTI CONSULTING INC | 19.85 | 5.26B |
Exponent, Inc. is an engineering and scientific consulting company, which provides engineering, scientific, environmental, and health consulting services. The company is headquartered in Menlo Park, California and currently employs 1,168 full-time employees. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. The company serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.
EXPONENT INC
149 Commonwealth Drive
Menlo Park CALIFORNIA 94025 US
CEO: Catherine Ford Corrigan
Employees: 1168
Phone: 16503269400
Exponent, Inc. is an engineering and scientific consulting company, which provides engineering, scientific, environmental, and health consulting services. The company is headquartered in Menlo Park, California and currently employs 1,168 full-time employees. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. The company serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.
The current stock price of EXPO is 70.15 USD. The price increased by 0.99% in the last trading session.
EXPONENT INC (EXPO) has a dividend yield of 1.73%. The yearly dividend amount is currently 0.
EXPO has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
EXPONENT INC (EXPO) operates in the Industrials sector and the Professional Services industry.
EXPONENT INC (EXPO) will report earnings on 2026-01-29, after the market close.
You can find the ownership structure of EXPONENT INC (EXPO) on the Ownership tab.
ChartMill assigns a technical rating of 1 / 10 to EXPO. When comparing the yearly performance of all stocks, EXPO is a bad performer in the overall market: 74.19% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to EXPO. Both the health and profitability get an excellent rating, making EXPO a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months EXPO reported a non-GAAP Earnings per Share(EPS) of 2.05. The EPS decreased by -0.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 18.35% | ||
| ROA | 13.77% | ||
| ROE | 26.02% | ||
| Debt/Equity | 0 |
9 analysts have analysed EXPO and the average price target is 87.21 USD. This implies a price increase of 24.32% is expected in the next year compared to the current price of 70.15.
For the next year, analysts expect an EPS growth of -1.05% and a revenue growth 4.12% for EXPO